课题基金 / 基金详情

Ethanol, Stress and Dopamine

Ethanol, Stress and Dopamine
乙醇、压力和多巴胺
批准号:
7813476
负责人:
SARA RAULERSON JONES
金额:
$25.73万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-22 至 2011-08-31

项目摘要

项目成果

SARA RAULERSON JONES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This competitive revision is in response to Notice Number (NOT-OD-09-058), Titled: "NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications". The cellular mechanisms that mediate the intoxicating and reinforcing effects of ethanol are not completely understood. However, considerable evidence supports the hypothesis that increased mesolimbic DA system activity is one of the important components of the reinforcing effects of many drugs of abuse, including ethanol. The hypocretins are recently identified neuropeptides that participate in the regulation of arousal and a variety of motivated behaviors. Emerging evidence indicates that the hypocretin system exerts a facilitatory influence on reward function and that these actions involve activation of dopamine neurons of the ventral tegmental area. For example blockade of hypocretin signaling reduces self-administration of ethanol and reduces the effects of ethanol on dopamine signaling. Given the potential that the hypocretin system regulates reward associated with drug abuse, the proposed studies will employ a multidisciplinary approach to investigate whether hypocretin regulates ethanol-induced changes in dopamine signaling. Studies will examine: 1) The extent to which the hypocretin system influences baseline and ethanol-induced levels of phasic dopamine signaling in the nucleus accumbens using in vitro fast scan voltammetry techniques; and 2) To what degree the hypocretin systems regulates baseline and ethanol-induced levels of tonic dopamine signaling in the nucleus accumbens using freely moving microdialysis. Completion of this work will provide pilot information on the extent to which hypocretin participates in reward processing, the extent to which these actions involve the mesolimbic DA system, and will offer insight into the neural mechanisms underlying the addiction process. Additionally this information and may help shape the foundations to generate novel pharmacotherapies for alcoholism. PUBLIC HEALTH RELEVANCE: The HCRT system may be an essential participant in the regulation of reinforcement properties of drugs of abuse, including ethanol. Understanding how this system modulates the neural correlates underlying ethanol-reinforcement processes, particularly as it relates to the mesolimbic DA system, could provide the basis for a rational drug design to treat addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biased Kappa Opioid Agonists as Non-addictive Analgesics
Biased Kappa Opioid Agonists as Non-addictive Analgesics
Biased Kappa Opioid Agonists as Non-addictive Analgesics
Pilot Projects Core
海外基金